DCH heads into tomorrow's Q1 earnings call with short sellers making a notable retreat — but starting from a level that still leaves the stock among the more heavily shorted names in the automotive parts space.
The clearest story this week is the unwinding of short positions. At 21.7% of the free float, short interest remains substantial. Yet it has fallen roughly 7.6% over the past week and is now down nearly 16% from the early-April peak of around 30.5M estimated shares short. The bulk of that unwind happened in a single session — April 23 saw shorts drop by more than 2 million shares in one day. Whether that represents conviction covering or tactical positioning ahead of results, the direction of travel is unambiguous: bears have been reducing exposure into the print.
The borrow market tells a slightly more nuanced story. Availability remains ample — the lending pool is far from exhausted, with the 12-month high on utilisation having reached 88% last year versus the current 12% reading, indicating plenty of room for new shorts if sentiment sours after results. Cost to borrow has edged higher, up roughly 26% week-on-week to 0.50%, though the absolute level remains low at just half a percent annualised. That combination — heavy but declining short interest, cheap and available borrow — suggests the covering seen this week was a choice, not a squeeze. Options positioning is mildly bullish relative to recent history: the put/call ratio sits at 0.14, slightly above its 20-day average of 0.13, but not at a level that signals meaningful hedging demand ahead of the event.
The Street's expectations are explicitly negative going into tomorrow. A piece published April 24 flagged that analysts estimate a decline in earnings for the quarter. Valuation is not demanding — EV/EBITDA sits around 3.0x on an enterprise value of roughly $4.2bn, with the P/E at approximately 8.9x. Revenue is estimated near $10.5bn and EBITDA near $1.35bn, but net income is thin at just over $12m on a reported basis, with net debt of more than $4bn weighting heavily on the balance sheet. One positive: the company's EPS surprise factor score ranks in the 99th percentile, meaning DCH has a strong track record of beating consensus estimates even when the bar is set low. That history matters in interpreting what "analysts estimate a decline" actually implies for the result.
Institutional and insider signals are worth watching alongside the numbers. BWS Financial issued a Buy rating on April 22, offering a degree of street-level conviction just days before the print. On the ownership side, BlackRock built a significant new position — adding over 14.4 million shares to reach 14.8% of the company — as recently reported as of March 31. That is a major institutional commitment to the name. Against that, insider activity in late February showed the chairman and CEO David Dauch, the president/COO, and the CFO all selling shares at $6.60 — well above the current $5.73. A director went the other way, buying 35,000 shares at $5.20 in March, a modest but directionally positive signal at current levels. The April 20 filing noting the "departure of directors or certain officers" added another layer of corporate noise ahead of results.
The earnings history provides the starkest context. The prior two quarterly reports produced day-one moves of -4.3% and -13.6% respectively, with the five-day drift extending the damage to -6.0% and -16.8%. Those are not small moves — the -13.6% print in February was a decisive negative reaction. Short sellers who trimmed positions this week into a stock trading near $5.73 are betting either that the result disappoints less than feared, or that the strong beat history provides a floor. Tomorrow's Q1 report is therefore less about whether DCH can grow revenue and more about whether the net income and guidance picture changes the narrative on a stock that has already been punished hard by the market this year.
See the live data behind this article on ORTEX.
Open DCH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
